Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 17 results.
User Information
Export Records
  1. 1.   Trans-ancestral fine-mapping of MHC reveals key amino acids associated with spontaneous clearance of hepatitis C in HLA-DQß1
  2. Valencia, Ana; Vergara, Candelaria; Thio, Chloe L; Vince, Nicolas; Douillard, Venceslas; Grifoni, Alba; Cox, Andrea L; Johnson, Eric O; Kral, Alex H; Goedert, James J; Mangia, Alessandra; Piazzolla, Valeria; Mehta, Shruti H; Kirk, Gregory D; Kim, Arthur Y; Lauer, Georg M; Chung, Raymond T; Price, Jennifer C; Khakoo, Salim I; Alric, Laurent; Cramp, Matthew E; Donfield, Sharyne M; Edlin, Brian R; Busch, Michael P; Alexander, Graeme; Rosen, Hugo R; Murphy, Edward L; Wojcik, Genevieve L; Carrington,Mary; Gourraud, Pierre-Antoine; Sette, Alessandro; Thomas, David L; Duggal, Priya
  3. American journal of human genetics. 2022, Jan 25; 109(2): 299-310.
  1. 2.   Molecular Signature and Immune Landscape of HCV-Associated Hepatocellular Carcinoma (HCC): Differences and Similarities with HBV-HCC
  2. De Battista, Davide; Zamboni, Fausto; Gerstein, Hannah; Sato, Shinya; Markowitz,Tovah; Lack,Justin; Engle, Ronald E; Farci, Patrizia
  3. Journal of hepatocellular carcinoma. 2021, Nov 21; 8: 1399-1413.
  1. 3.   Dynamics of hepatitis C epidemic among people living with HIV in Estonia based on Estonian HIV cohort study
  2. Kase, Kerstin; Avi, Radko; Toompere, Karolin; Rajasaar, Heli; Pauskar, Merit; Soodla, Pilleriin; Jõgeda, Ene-Ly; Zilmer, Kai; Lutsar, Irja; Huik,Kristi
  3. BMC infectious diseases. 2021, Aug 10; 21(1): 792.
  1. 4.   Meeting Overview: Interferon Lambda-Disease Impact and Therapeutic Potential
  2. O'Brien, Thomas R; Young,Howard; Donnelly, Raymond P; Prokunina-Olsson, Ludmila
  3. Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research. 2019, OCT 1; 39(10): 586-591.
  1. 5.   Molecular Basis of Encapsidation of Hepatitis C Virus Genome
  2. Shi, Scarlett; Suzuki, Tetsuro
  3. Frontiers in Microbiology. 2018, Mar 07; 9: 396.
  1. 6.   Three-dimensional structure of the 3 ' X-tail of hepatitis C virus RNA in monomeric and dimeric states
  2. Cantero-Camacho, Angel; Fan, Lixin; Wang, Yun-Xing; Gallego, José
  3. RNA (New York, N.Y.). 2017, Sep 01; 23(9): 1465-1476.
  1. 7.   Rapid changes in peripheral lymphocyte concentrations during interferon-free treatment of chronic hepatitis C virus infection
  2. Meissner, Eric G; Kohli, Anita; Higgins, Jeanette; Lee, Yu-Jin; Prokunina, Olga; Wu, David; Orr, Cody; Masur, Henry; Kottilil, Shyam
  3. Hepatology communications. 2017, Sep; 1(7): 586-594.
  1. 8.   Twice-weekly pegylated interferon-alpha-2a and ribavirin results in superior viral kinetics in HIV/hepatitis C virus co-infected patients compared to standard therapy
  2. Murphy, A. A.; Herrmann, E.; Osinusi, A. O.; Wu, L.; Sachau, W.; Lempicki, R. A.; Yang, J.; Chung, T. L.; Wood, B. J.; Haagmans, B. L.; Kottilil, S.; Polis, M. A.
  3. Aids. 2011, Jun; 25(9): 1179-1187.
  1. 9.   CCL5: A Double-Edged Sword in Host Defense Against the Hepatitis C Virus
  2. Katsounas, A.; Schlaak, J. F.; Lempicki, R. A.
  3. International Reviews of Immunology. 2011, Oct-Dec; 30(5-6): 366-378.
  1. 10.   Development of therapeutics for chronic HCV infection
  2. Huang, Z.; Murray, M. G.; Secrist, J. A.
  3. Antiviral Research. 2006, Sep; 71(2-3): 351-362.
  1. 11.   Single nucleotide polymorphisms and haplotypes in the IL10 region associated with HCV clearance
  2. Oleksyk, T. K.; Thio, C. L.; Truelove, A. L.; Goedert, J. J.; Donfield, S. M.; Kirk, G. D.; Thomas, D. L.; O'Brien, S. J.; Smith, M. W.
  3. Genes and Immunity. 2005, JUN; 6(4): 347-357.
  1. 12.   MICA and recovery from hepatitis C virus and hepatitis B virus infections
  2. Karacki, P. S.; Gao, X.; Thio, C. L.; Thomas, D. L.; Goedert, J. J.; Vlahov, D.; Kaslow, R.; Strathdee, S.; Hilgartner, M. W.; O'Brien, S. J.; Carrington, M.
  3. Genes and Immunity. 2004 5(4): 261-266.
  1. 13.   An analysis of tumor necrosis factor alpha gene polymorphisms and haplotypes with natural clearance of hepatitis C virus infection
  2. Thio, C. L.; Goedert, J. J.; Mosbruger, T.; Vlahov, D.; Strathdee, S. A.; O'Brien, S.; Astemborski, J.; Thomas, D. L.
  3. Genes and Immunity. 2004 5(4): 294-300.
  1. 14.   Genetic heterogeneity and molecular epidemiology of GB virus C hepatitis G virus in China
  2. An, P.; Luo, H.; Lu, T.; O'Brien, S. J.; Winkler, C.
  3. Journal of Human Virology. 2000, NOV-DEC; 3(6): 299-305.
  1. 15.   DNA immunization of mice and macaques with plasmids encoding hepatitis C virus envelope E2 protein expressed intracellularly and on the cell surface
  2. Forns, X.; Emerson, S. U.; Tobin, G. J.; Mushahwar, I. K.; Purcell, R. H.; Bukh, J.
  3. Vaccine. 1999 17(15-16): 1992-2002.
  1. 16.   Phenotypic expressions of CCR5-Delta 32/Delta 32 homozygosity
  2. Nguyen, G. T.; Carrington, M.; Beeler, J. A.; Dean, M.; Aledort, L. M.; Blatt, P. M.; Cohen, A. R.; DiMichele, D.; Eyster, M. E.; Kessler, C. M.; Konkle, B.; Leissinger, C.; Luban, N.; O'Brien, S. J.; Goedert, J. J.; O'Brien, T. R.
  3. Jaids-Journal of Acquired Immune Deficiency Syndromes. 1999 22(1): 75-82.
  1. 17.   Hepatitis C Virus Infection in the Mothers and Infants Cohort Study
  2. Granovsky, M. O.; Minkoff, H. L.; Tess, B. H.; Waters, D.; Hatzakis, A.; Devoid, D. E.; Landesman, S. H.; Rubinstein, A.; Dibisceglie, A. M.; Goedert, J. J.
  3. Pediatrics. 1998 102(2): 355-359.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel